醫(yī)療特長(zhǎng)：
腫瘤放射治療的臨床工作及相關(guān)研究,，包括頭頸腫瘤,、鼻咽癌、口腔頜面腫瘤,，神經(jīng)系統(tǒng)腫瘤等病種放射治療,、早期診斷、個(gè)體化綜合治療,、療效預(yù)測(cè),、預(yù)后及放射損傷研究,。頭頸腫瘤多項(xiàng)研究發(fā)表于國(guó)際主流雜志。主持國(guó)家自然科學(xué)基金,、廣東省自然科學(xué)基金和華南腫瘤學(xué)國(guó)家重點(diǎn)實(shí)驗(yàn)室開放基金多項(xiàng),。
研究方向：①頭頸腫瘤調(diào)強(qiáng)放療、圖像引導(dǎo)放療及自適應(yīng)放療,；②頭頸腫瘤調(diào)強(qiáng)放射治療個(gè)體化照射范圍,；③頭頸部正常組織的放射損傷及防護(hù)。
主要教育和工作經(jīng)歷：
1996-09至2001-06 中山醫(yī)科大學(xué)臨床醫(yī)學(xué)學(xué)士學(xué)位
2001-09至2004-06 中山大學(xué)腫瘤防治中心腫瘤學(xué)碩士學(xué)位
2008-09至2011-06 中山大學(xué)腫瘤防治中心腫瘤學(xué)博士學(xué)位
2004-07至2008-08 云南省腫瘤醫(yī)院放射治療科醫(yī)師
2011-07至現(xiàn)在 中山大學(xué)附屬第一醫(yī)院放射治療科住院/主治/副主任醫(yī)師
社會(huì)兼職：廣州市抗癌協(xié)會(huì)腫瘤放射治療專業(yè)委員會(huì)委員
論著：
1. Shen GP#, Pan QH#, Hong MH#, Qin HD, Xu YF, Chen LZ, Feng QS, Jorgensen TJ, Shugart YY, Zeng YX, Jia WH. Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy Cantonese. Int J Cancer. 2011 Sep 15;129(6):1459-66. (IF=5.4)
2. Shen GP, Xu FH, He F, Ruan HL, Cui C, Chen LZ, Zeng YX, Jia WH. Pretreatment lifestyle behaviors as survival predictors for patients with nasopharyngeal carcinoma. PLoS One. 2012;7(5):e36515. (IF=3.7)
3. He JR#, Shen GP#, Ren ZF, Qin H, Cui C, Zhang Y, Zeng YX, Jia WH. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012 Dec;34(12):1769-76. (IF=2.8)
4. Zhang MX#, Li J#, Shen GP#, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015 Aug 26.(IF=6.1)
